2.3 Å resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition
暂无分享,去创建一个
A. Bartesaghi | S. Subramaniam | P. Wipf | J. Milne | M. Arkin | Soojay Banerjee | A. Merk | P. Rao | Stacie L. Bulfer | Yongzhao Yan | Neal Green | B. Mroczkowski | R. Neitz | V. Falconieri | R. Deshaies | D. Huryn | R. J. Neitz
[1] T. Nilsson,et al. Cytosolic ATPases, p97 and NSF, are sufficient to mediate rapid membrane fusion , 1999, The EMBO journal.
[2] M van Heel,et al. Structure of the AAA ATPase p97. , 2000, Molecular cell.
[3] A. Wilkinson,et al. AAA+ superfamily ATPases: common structure–diverse function , 2001, Genes to cells : devoted to molecular & cellular mechanisms.
[4] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[5] Hisao Kondo,et al. Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47 , 2004, The EMBO journal.
[6] P. Hanson,et al. AAA+ proteins: have engine, will work , 2005, Nature Reviews Molecular Cell Biology.
[7] R. Isaacson,et al. Conformational changes in the AAA ATPase p97–p47 adaptor complex , 2006, The EMBO journal.
[8] W. Weis,et al. Improved structures of full-length p97, an AAA ATPase: implications for mechanisms of nucleotide-dependent conformational change. , 2008, Structure.
[9] Randy J Read,et al. Automated structure solution with the PHENIX suite. , 2008, Methods in molecular biology.
[10] Vincent B. Chen,et al. Correspondence e-mail: , 2000 .
[11] L. Esser,et al. A novel ATP‐dependent conformation in p97 N–D1 fragment revealed by crystal structures of disease‐related mutants , 2010, The EMBO journal.
[12] R. Deshaies,et al. Development of p97 AAA ATPase inhibitors , 2011, Autophagy.
[13] N. Vij,et al. Critical Role of VCP/p97 in the Pathogenesis and Progression of Non-Small Cell Lung Carcinoma , 2011, PloS one.
[14] Steven J Brown,et al. Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways , 2011, Proceedings of the National Academy of Sciences.
[15] H. Schindelin,et al. Hierarchical binding of cofactors to the AAA ATPase p97. , 2011, Structure.
[16] W. Chia,et al. ATP Binding to p97/VCP D1 Domain Regulates Selective Recruitment of Adaptors to Its Proximal N-Domain , 2012, PloS one.
[17] B. le Bail,et al. Sorafenib-Mediated Targeting of the AAA+ ATPase p97/VCP Leads to Disruption of the Secretory Pathway, Endoplasmic Reticulum Stress, and Hepatocellular Cancer Cell Death , 2012, Molecular Cancer Therapeutics.
[18] P. Freemont,et al. The Role of the N-Domain in the ATPase Activity of the Mammalian AAA ATPase p97/VCP , 2012, The Journal of Biological Chemistry.
[19] A. Isacchi,et al. Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death. , 2013, Nature chemical biology.
[20] D. Xia,et al. Altered Intersubunit Communication Is the Molecular Basis for Functional Defects of Pathogenic p97 Mutants* , 2013, The Journal of Biological Chemistry.
[21] R. Deshaies,et al. Structure–Activity Relationship Study Reveals ML240 and ML241 as Potent and Selective Inhibitors of p97 ATPase , 2013, ChemMedChem.
[22] T. Ando,et al. High-speed atomic force microscopic observation of ATP-dependent rotation of the AAA+ chaperone p97. , 2013, Structure.
[23] A. Isacchi,et al. Alkylsulfanyl-1,2,4-triazoles, a new class of allosteric valosine containing protein inhibitors. Synthesis and structure-activity relationships. , 2013, Journal of medicinal chemistry.
[24] P. Freemont,et al. Inter-ring rotations of AAA ATPase p97 revealed by electron cryomicroscopy , 2014, Open Biology.
[25] S. Suh,et al. Structural Basis for Ovarian Tumor Domain-containing Protein 1 (OTU1) Binding to p97/Valosin-containing Protein (VCP)* , 2014, The Journal of Biological Chemistry.
[26] Correction to Palladium-Catalyzed Aerobic Oxidative Cyclization of N-Aryl Imines: Indole Synthesis from Anilines and Ketones , 2014 .
[27] Hemant D. Tagare,et al. The Local Resolution of Cryo-EM Density Maps , 2013, Nature Methods.
[28] H. Meyer,et al. The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis , 2014, Journal of Cell Science.
[29] Henry J. Lin,et al. Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains. , 2014, Journal of molecular biology.
[30] R. Deshaies,et al. Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy , 2014, BMC Biology.
[32] P. Wipf,et al. Structure-Activity Study of Bioisosteric Trifluoromethyl and Pentafluorosulfanyl Indole Inhibitors of the AAA ATPase p97. , 2015, ACS medicinal chemistry letters.
[33] A. Bartesaghi,et al. 2.2 Å resolution cryo-EM structure of β-galactosidase in complex with a cell-permeant inhibitor , 2015, Science.
[34] J. L. La Clair,et al. Inhibitors of the AAA+ Chaperone p97 , 2015, Molecules.
[35] Henry J. Lin,et al. Evaluating p97 Inhibitor Analogues for Their Domain Selectivity and Potency against the p97–p47 Complex , 2015, ChemMedChem.
[36] A Fragment-Based Ligand Screen Against Part of a Large Protein Machine , 2015, Journal of biomolecular screening.
[37] J. Flammer,et al. Mitochondrial function in neuronal cells depends on p97/VCP/Cdc48-mediated quality control , 2015, Front. Cell. Neurosci..
[38] M. K. Lemberg,et al. Clipping or Extracting: Two Ways to Membrane Protein Degradation. , 2015, Trends in cell biology.
[39] Ana Luísa Carvalho,et al. SUMOylation of the brain-predominant Ataxin-3 isoform modulates its interaction with p97. , 2015, Biochimica et biophysica acta.
[40] Donna D. Zhang,et al. Withaferin A Analogs That Target the AAA+ Chaperone p97. , 2015, ACS chemical biology.
[41] R. Sauer,et al. Origin and Functional Evolution of the Cdc48/p97/VCP AAA+ Protein Unfolding and Remodeling Machine. , 2015, Journal of molecular biology.